Cure of acute myelocytic leukemia in adults: A reality

Robert B. Geller, Rein Saral, Judith E. Karp, George W. Santos, Philip J. Burke

Research output: Contribution to journalReview articlepeer-review

Abstract

Adult acute myelocytic leukemia (AML) is a curable disease in responsive patients with aggressive treatment in remission. Over the past decade at the Johns Hopkins Oncology Center, AML has been treated with either allogeneic bone marrow transplantation or with intensive timed sequential treatment using high dose cytarabine in remission. With either treatment modality comparable cure rates were obtained. The role, if any, of randomized trials to adequately determine the preferred treatment for appropriate patients has yet to be defined.

Original languageEnglish (US)
Pages (from-to)313-315
Number of pages3
JournalLeukemia
Volume4
Issue number5
StatePublished - May 1990

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Cure of acute myelocytic leukemia in adults: A reality'. Together they form a unique fingerprint.

Cite this